Pittsburgh's latest venture numbers tell a story most early-stage founders will recognise. According to Technical.ly, citing the PitchBook-NVCA Venture Monitor, companies in the Pittsburgh metro raised $168.5 million across 22 deals in Q3 2026. Both figures were below the region's average.
The total also hides how concentrated the money was. The top three deals took about 80% of the capital, and one $97 million Series B accounted for more than half on its own. Meanwhile, 19 of the 22 deals were small rounds averaging about $1.8 million. Plenty of companies are getting started. Far fewer are getting the next cheque.
The gap is in the middle
Local investors quoted in the piece were direct about where the problem sits. Malcolm Handelsman of Active Angels Network described the missing component as "the late seed round that carries a company to the Series A round." Most of the quarter's top deals were either seed or later-stage, with little in between.
This is not only a Pittsburgh story. The NVCA notes that capital is increasingly concentrated nationally, and that emerging and mid-sized firms are finding it harder to raise their next funds. As large funds get larger, money pools at the top. The round that turns a promising seed company into a credible Series A candidate is often too big for an angel group to lead and too early for most institutional funds.
Why that round decides outcomes
The stretch between angel and Series A is where a company has to prove the thing a Series A investor will pay for. That might be first meaningful revenue, a pilot that converts into a contract, a regulatory submission or a manufacturing process that works at volume.
Companies that fund this stage properly reach Series A with evidence. Companies that cannot often raise on poor terms, cut back before the proof point or stall altogether. The quality of the idea rarely changes between those outcomes. Access to the right capital at the right moment does.
Where we focus
Albion Trinity Capital is built for this stage: supporting founders from angel to institutional capital. Our partners have long invested through angel networks. That gives us early sight of companies, often well before institutional funds arrive, and lets us back them in the round that carries them to Series A.
At this stage we look for a few things:
A technical or clinical risk that is already partly retired, not just a plan to retire it.
Early customer pull, such as pilots, letters of intent or first revenue.
A clear use of funds, setting out what the next 18 to 24 months of capital will prove.
A syndicate that can follow on, so the company is not stranded at the next round.
The remedies suggested in the Technical.ly piece, from pooling angel capital and co-investing to securing pro-rata rights early, are the same disciplines that make this stage work.
The takeaway
Headline funding totals can hide what most founders actually experience. The ecosystems that produce breakout companies are not simply the ones with the biggest rounds. They are the ones where good companies make it through the middle.
This article reflects the views of Albion Trinity Capital as of the date of publication and is provided for general information only. It is not investment advice or an offer or solicitation to buy or sell any security or interest in any fund. Third-party data is cited from sources believed to be reliable but has not been independently verified.